Many investors are enamored with how China can keep a 7%+ growth rate going as the rest of the world only begins to dig out from recent economic events. There are many reasons this GDP growth rate has been able to be maintained although a large capital surplus of US dollars and a burgeoning middle-class … Continue reading “China’s Major Cities Face Reality of Commercial Real Estate Bubble”
One company that has been steadily evolving is the International Stem Cell Corporation. Located in California, the biotechnology corporation has earned a stellar reputation by focusing on therapeutic and research products. Today, International Stem Cell Corporation took a major step towards enhancing its future with the announcement that they have provided a strategic update on … Continue reading “International Stem Cell Corp. (ISCO.OB) Continues Climb by Providing Strategic Update on Skin Care Program”
GWS Technologies, Inc. is an alternative energy technology company focused on developing and marketing solar and wind-powered renewable energy products and solutions for utility-grade and commercial applications. The company’s name, GWS, stands for “GreenWindSolar”. Recognizing that coal, oil, and natural gas are nonrenewable, finite resources will eventually dwindle, becoming too expensive or too environmentally damaging … Continue reading “Beacon Equity Research Featured Company: GWS Technologies Inc. (GWSC.OB)”
One company that is truly on the move is Total Nutraceutical Solutions (TNS). Located in Stevenson, Washington, TNS has become a global leader in mushroom research and development with their focus on discovering, formulating and marketing products comprised primarily of organic natural whole mushroom foods which contain bioactive nutrients with an abundance of health benefits. … Continue reading “Total Nutraceutical Solutions (TNUS.OB) Acquires Ergothioneine Transporter License”
Fremont Michigan InsuraCorp, Inc. reported net income of $1.9 million, or $1.07 per share, in the fourth quarter of 2009. The company earned only $0.23 million, or $0.13 per diluted share, in the same quarter in 2008. Fremont Michigan InsuraCorp, Inc. earned $4.2 million, or $2.38 per diluted share, for the full year 2009, compared … Continue reading “Fremont Michigan InsuraCorp, Inc. (FMMH.OB) Reports Profit In 2009”
TapImmune, Inc. is a biotechnology company focused on developing innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company’s lead product, the TAP vaccine, is a key component of a mechanism that moves characteristic markers called antigens to the surfaces of cells. Without TAP, there is a large reduction in presentation … Continue reading “Beacon Equity Research Featured Company: TapImmune, Inc. (TPIV.OB)”
SANUWAVE Health Inc. today announced the publication of a European scientific study covering the company’s dermaPACE burn treatment device. The report details the successful treatment of severe burns using SANUWAVE’s device in a paper titled Extracorporeal Shock Waves, a New Non-Surgical Method to Treat Severe Burns in BURNS (www.burnsjournal.com). According to the article, the study … Continue reading “SANUWAVE Health Inc.’s (SNWV.OB) Burn Treatment Device Receives Positive Review in Industry Publication”
Today, Genta Inc. announced that the company has begun treatment of the first subject in a new Phase 2 trial of tesetaxel, used in relation to advanced melanoma. The study was initiated at the Anderson Cancer Center in Houston, TX, the lead center for Genta’s last two clinical trials in melanoma that have enrolled approximately … Continue reading “Genta Inc. (GETA.OB) Begins Phase 2 Trial of Tesetaxel”
The hepatitis C virus (HCV), the most common cause of viral hepatitis, results in inflammation of the liver. The American Association of Liver Disease estimates that more than 170 million people are infected with HCV around the world; without proper treatment, chronic hepatitis can lead to permanent liver damage, including liver failure or death. Despite … Continue reading “Achillion Pharmaceuticals Inc. (ACHN) Announces Lead Candidate for Hepatitis C Treatment”
Genta Inc., the biopharma company with a wide-ranging portfolio focused primarily on DNA/RNA and Small Molecule medicines, announced a strategic alliance with MedCI LLC, the well-known life-science consulting services company, with the goal of finding licensing partners for Genta’s small molecule oncology compound tesetaxel. Part of Genta’s overall oncology approach, tesetaxel is the No. 1 … Continue reading “Genta Inc. (GETA.OB) Forms Strategic Alliance with MedCI to License Cancer Drug”
